Black Rock Inc. Galecto, Inc. Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

A detailed history of Black Rock Inc. transactions in Galecto, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 21,205 shares of GLTO stock, worth $119,172. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,205
Previous 51,025 58.44%
Holding current value
$119,172
Previous $39,000 76.92%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$0.47 - $0.76 $14,015 - $22,663
-29,820 Reduced 58.44%
21,205 $9,000
Q1 2024

May 10, 2024
SELL
$0.6 - $0.89 $648 - $962
-1,081 Reduced 2.07%
51,025 $39,000
Q4 2023

Feb 13, 2024
SELL
$0.52 - $0.78 $245 - $368
-472 Reduced 0.9%
52,106 $37,000
Q3 2023

Nov 13, 2023
SELL
$0.56 - $3.17 $123,702 - $700,243
-220,897 Reduced 80.77%
52,578 $37,000
Q2 2023

Aug 11, 2023
BUY
$1.68 - $2.84 $431,447 - $729,351
256,814 Added 1541.41%
273,475 $689,000
Q3 2022

Nov 14, 2022
BUY
$1.59 - $60.0 $3,970 - $149,820
2,497 Added 17.63%
16,661 $31,000
Q4 2021

Feb 10, 2022
BUY
$2.3 - $3.58 $11,976 - $18,641
5,207 Added 58.13%
14,164 $42,000
Q3 2021

Nov 09, 2021
BUY
$3.59 - $5.0 $5,934 - $8,265
1,653 Added 22.63%
8,957 $32,000
Q2 2021

Aug 11, 2021
BUY
$4.63 - $8.0 $33,817 - $58,432
7,304 New
7,304 $37,000

Others Institutions Holding GLTO

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Galecto, Inc.

GLTO Quotes by TradingView
  • Ticker GLTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,395,700
  • Market Cap $143M
  • Description
  • Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...
More about GLTO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email